Zyneyro (private company)
		See something wrong or missing? Let us know
	
Offices:Copenhagen
			
			Industry:BiotechHealth servicesPharma
			Business model:B2B
			
			Zyneyro is a spin-out from the University of Copenhagen and Marigold Innovation, developing next-generation treatments for chronic pain without the current typical side effects.
					Investors:
					
						
							we tracked 1 investor
						
					
				
				
					You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
					Investments 2.17M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Zyneyro
| Name | Criteria | |
|---|---|---|
![]()  | 
					
						Athera
						 58% 
					 | 
					
						
  | 
				
![]()  | 
					
						AttgeNO
						 58% 
					 | 
					
						
  | 
				
![]()  | 
					
						Biotts
						 58% 
					 | 
					
						
  | 
				
![]()  | 
					
						Oui
						 58% 
					 | 
					
						
  | 
				
![]()  | 
					
						Pulmobiotics S.L
						 58% 
					 | 
					
						
  | 
				
![]()  | 
					
						PEP-Therapy
						 58% 
					 | 
					
						
  | 
				
![]()  | 
					
						Brinter
						 58% 
					 | 
					
						
  | 
				
![]()  | 
					
						Colzyx
						 58% 
					 | 
					
						
  | 
				
![]()  | 
					
						CimCure
						 58% 
					 | 
					
						
  | 
				
![]()  | 
					
						Mable
						 58% 
					 | 
					
						
  | 
				








 Belgium
 Austria
 Germany
 Switzerland
 Estonia
 Iceland
 Latvia
 Lithuania
 Norway
 Ireland
 Italy
 Portugal